This product has not been evaluated by SAHPRA. For information purposes only — not intended to diagnose, treat, cure or prevent any disease.
Weight LossPeptide vialGLP-1GIPWeight Loss
UPA Tirzepatide
Dual GIP + GLP-1 agonist. Next-generation weight management.
R 2 150
30 mg vial
Dual mechanismHits both GIP and GLP-1 receptors for stronger metabolic effect.
Greater fat lossClinical trials show larger weight reduction vs. single-pathway GLP-1s.
Blood sugar controlPowerful insulin sensitization.
Appetite regulationSubstantial reduction in hunger and food cravings.
Tirzepatide is a dual agonist binding both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors. This dual action drives larger improvements in glucose regulation and weight than GLP-1 mono-agonism.
More in Weight Loss
You might also like
Weight LossR 195
90 capsules
Natural Fat Burner
A daily botanical + thermogenic capsule designed to support metabolism and an active routine — from the Slender Living line.
View details →
Weight LossR 669
30 capsules
S30 Extreme Fat Burner
An extreme thermogenic fat-burner capsule — formulated for serious weight-loss routines and hard-training days.
View details →
Weight LossR 689
30 capsules
V30 Hardcore Fat Burner
A hardcore fat-burner capsule for advanced users — intense thermogenic support to push past plateaus.
View details →
Regulatory
This product has not been evaluated by the South African Health Products Regulatory Authority (SAHPRA).
For information purposes only — not intended to diagnose, treat, cure or prevent any disease.